Condition: HR+/HER2- Breast Cancer · Sponsor: BeOne Medicines
The purpose of this study is to investigate the efficacy and safety of BGB-43395 in combination with letrozole compared with investigator's choice of cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) in combination with letrozole in patients with advanced or metastatic hormone receptor positive (HR+)/human epidermal growth factor receptor 2 negative (HER2-) breast cancer (BC) who have not received prior systemic treatment for advanced or metastatic disease.
This description comes directly from the study's public registry record.
Study Director · 877-828-5568 · clinicaltrials@beonemed.com
Always discuss trial participation with your own doctor first.
| Alabama Oncology Princeton | Birmingham, Alabama, United States | Recruiting |
| Alaska Oncology and Hematology, Llc | Anchorage, Alaska, United States | Recruiting |
| Ironwood Cancer and Research Centers Chandler Ii | Chandler, Arizona, United States | Recruiting |
| Helios Clinical Research the Oncology Institute Fountain Valley | Fountain Valley, California, United States | Recruiting |
| Brcr Coral Springs | Coral Springs, Florida, United States | Recruiting |
| Florida Clinical Trials Group Plantation | Plantation, Florida, United States | Recruiting |
| Hematology Oncology Associates of the Treasure Coast | Port Saint Lucie, Florida, United States | Recruiting |
| Florida Clinical Trials Group Tamarac | Tamarac, Florida, United States | Recruiting |
| Hope and Healing Cancer Services | Hinsdale, Illinois, United States | Recruiting |
| Cancer Care Specialists For Illinois | O'Fallon, Illinois, United States | Recruiting |
| Fort Wayne Medical Oncology and Hematology | Fort Wayne, Indiana, United States | Recruiting |
| Owensboro Health Mitchell Memorial Cancer Center | Owensboro, Kentucky, United States | Recruiting |
+ 62 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07492641